Tofacitinib: A Review in Rheumatoid Arthritis

2017/11/14 by Sohita Dhillon · 27 citations
Medicine · #Rheumatoid Arthritis Research and Therapies #Autoimmune and Inflammatory Disorders Research #Systemic Lupus Erythematosus Research

paper · doi:10.1007/s40265-017-0835-9

Cited by

• Clinical and experimental treatment of primary humoral immunodeficiencies
• Development and validation of blood-based diagnostic biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using EpiSwitch® 3-dimensional genomic regulatory immuno-genetic profiling
• A New Perspective: Mitochondrial Stat3 as a Regulator for Lymphocyte Function. [europepmc]
• Current Therapeutic Options in the Treatment of Rheumatoid Arthritis. [europepmc]
• IFN-γ enhances cell-mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus. [europepmc]
• The JAK inhibitor tofacitinib ameliorates immune‑mediated liver injury in mice. [europepmc]
• The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19. [europepmc]
• Targeting IFN/STAT1 Pathway as a Promising Strategy to Overcome Radioresistance. [europepmc]
• Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates. [europepmc]
• The JAK Inhibitor Tofacitinib Rescues Intestinal Barrier Defects Caused by Disrupted Epithelial-macrophage Interactions. [europepmc]
• Paroxetine-Overview of the Molecular Mechanisms of Action. [europepmc]
• Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway. [europepmc]
• Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis. [europepmc]
• Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies. [europepmc]
• Role of Janus Kinase Inhibitors in Therapy of Psoriasis. [europepmc]
• Calming the cytokine storm of COVID-19 through inhibition of JAK2/STAT3 signaling. [europepmc]
• Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis. [europepmc]
• Toward Overcoming Treatment Failure in Rheumatoid Arthritis. [europepmc]
• Therapeutic potential of pyrrole and pyrrolidine analogs: an update. [europepmc]
• Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis. [europepmc]
• JAK: Not Just Another Kinase. [europepmc]
• The development of COVID-19 treatment. [europepmc]
• Signaling pathways in rheumatoid arthritis: implications for targeted therapy. [europepmc]
• Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. [europepmc]
• Amino acid metabolism in health and disease. [europepmc]
• Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets. [europepmc]
• Targeting cytokine and chemokine signaling pathways for cancer therapy. [europepmc]